Search Results - "MCIVOR, R. S"

Refine Results
  1. 1

    Visualization of spinal afferent innervation in the mouse colon by AAV8‐mediated GFP expression by Schuster, D. J., Dykstra, J. A., Riedl, M. S., Kitto, K. F., Honda, C. N., McIvor, R. S., Fairbanks, C. A., Vulchanova, L.

    Published in Neurogastroenterology and motility (01-02-2013)
    “…Background  Primary afferent neurons whose cell bodies reside in thoracolumbar and lumbosacral dorsal root ganglia (DRG) innervate colon and transmit sensory…”
    Get full text
    Journal Article
  2. 2

    Increased longevity and metabolic correction following syngeneic BMT in a murine model of mucopolysaccharidosis type I by Wolf, D A, Lenander, A W, Nan, Z, Braunlin, E A, Podetz-Pedersen, K M, Whitley, C B, Gupta, P, Low, W C, McIvor, R S

    Published in Bone marrow transplantation (Basingstoke) (01-09-2012)
    “…Mucopolysaccharidosis type I (MPS I) is an autosomal recessive inherited disease caused by deficiency of the glycosidase α- L -iduronidase (IDUA). Deficiency…”
    Get full text
    Journal Article
  3. 3

    High-titer lentiviral vectors stimulate fetal calf serum-specific human CD4 T-cell responses: implications in human gene therapy by Bao, L, Guo, H, Huang, X, Tammana, S, Wong, M, McIvor, R S, Zhou, X

    Published in Gene therapy (01-06-2009)
    “…Human immunodeficiency virus-1-derived lentiviral vectors have been increasingly used for gene delivery in both pre-clinical and clinical models. Numerous…”
    Get full text
    Journal Article
  4. 4

    The Sleeping Beauty transposon system: a non-viral vector for gene therapy: Gene Therapy by ARONOVICH, Elena L, MCIVOR, R. Scott, HACKETT, Perry B

    Published in Human molecular genetics (15-04-2011)
    “…Over the past decade, the Sleeping Beauty (SB) transposon system has been developed as the leading non-viral vector for gene therapy. This vector combines the…”
    Get full text
    Journal Article
  5. 5

    In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase by Gori, J L, Tian, X, Swanson, D, Gunther, R, Shultz, L D, McIvor, R S, Kaufman, D S

    Published in Gene therapy (01-02-2010)
    “…Human embryonic stem cells (hESCs) provide a novel source of hematopoietic and other cell populations suitable for gene therapy applications. Preclinical…”
    Get full text
    Journal Article
  6. 6

    Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I by PAN, D, ARONOVICH, E, MCIVOR, R. S, WHITLEY, C. B

    Published in Gene therapy (01-11-2000)
    “…To optimize a gene transfer system for hematopoietic stem cell gene therapy of patients with mucopolysaccharidosis (MPS) type I, 10 retroviral vectors were…”
    Get full text
    Journal Article
  7. 7

    Protection of Mice From Lethal Doses of Methotrexate by Transplantation With Transgenic Marrow Expressing Drug-Resistant Dihydrofolate Reductase Activity by May, Chad, Gunther, Roland, Mclvor, R.Scott

    Published in Blood (15-09-1995)
    “…Marrow cells from previously established lines of transgenic mice expressing either of two different methotrexate (MTX)-resistant dihydrofolate reductases…”
    Get full text
    Journal Article
  8. 8

    Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application by McIvor, R S

    Published in Bone marrow transplantation (Basingstoke) (01-12-1996)
    “…Although methotrexate (MTX) and other antifolates are effective antitumor chemotherapeutic agents, their utility is limited by toxicity for normal…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Maintenance of differential methotrexate toxicity between cells expressing drug-resistant and wild-type dihydrofolate reductase activities in the presence of nucleosides through nucleoside transport inhibition by Warlick, Christopher A, Sweeney, Colin L, McIvor, R.Scott

    Published in Biochemical pharmacology (15-01-2000)
    “…Methotrexate (MTX), a potent inhibitor of dihydrofolate reductase (DHFR), has been used widely as a chemotherapeutic agent and as a selective agent for cells…”
    Get full text
    Journal Article
  11. 11

    Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated by counterflow elutriation by JAMES, R. I, MAY, C, DIERS, M. D, WAGNER, J. E, MCIVOR, R. S

    Published in Bone marrow transplantation (Basingstoke) (02-10-1999)
    “…Introduction of genes conferring drug resistance into hematopoietic cells may allow for improved chemotherapy by protection of normally drug-sensitive cells…”
    Get full text
    Journal Article
  12. 12

    Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene by Hartung, S D, Reddy, R G, Whitley, C B, McIvor, R S

    Published in Human gene therapy (01-09-1999)
    “…Mucopolysaccharidosis type I (MPS I), a deficiency in the lysosomal enzyme alpha-L-iduronidase (IDUA), is characterized by skeletal abnormalities,…”
    Get more information
    Journal Article
  13. 13

    Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses by MCIVOR, R. S, JOHNSON, M. J, MILLER, A. D, PITTS, S, WILLIAMS, S. R, VALERIO, D, MARTIN, D. W. JR, VERMA, I. M

    Published in Molecular and Cellular Biology (01-02-1987)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14

    Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate by Vinh, D B, McIvor, R S

    “…To determine the effect of in vivo pharmacological selective pressure on the insertion and expression of new gene sequences, retroviral-mediated transfer of a…”
    Get more information
    Journal Article
  15. 15

    Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate by James, R I, May, C, Vagt, M D, Studebaker, R, McIvor, R S

    Published in Experimental hematology (01-11-1997)
    “…Expression of the arg22, drug-resistant variant of dihydrofolate reductase (DHFR) in hematopoietic cells has been demonstrated to confer resistance to…”
    Get more information
    Journal Article
  16. 16

    Intron requirement for expression of the human purine nucleoside phosphorylase gene by JONSSON, J. J, FORESMAN, M. D, WILSON, N, MCIVOR, R. S

    Published in Nucleic acids research (25-06-1992)
    “…Abbreviated purine nucleoside phosphorylase (PNP) genes were engineered to determine the effect of introns on human PNP gene expression. PNP minigenes…”
    Get full text
    Journal Article
  17. 17

    Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells by MCIVOR, R. S, SIMONSEN, C. C

    Published in Nucleic acids research (11-12-1990)
    “…Dihydrofolate reductase (DHFR) cDNA sequences were isolated from a methotrexate-resistant mouse L5178Y cell line previously shown to contain…”
    Get full text
    Journal Article
  18. 18

    A human purine nucleoside phosphorylase deficiency caused by a single base change by Williams, S.R., Gekeler, V., McIvor, R.S., Martin, D.W.

    Published in The Journal of biological chemistry (15-02-1987)
    “…Purine nucleoside phosphorylase (PNP) deficiency in humans is associated with a severe defect in T-lymphocyte function. The mutant gene was cloned from one…”
    Get full text
    Journal Article
  19. 19

    Methotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity by May, C, James, R I, Gunther, R, McIvor, R S

    “…Methotrexate (MTX) dose-escalation studies were conducted in two inbred lines of FVB/N transgenic mice expressing distinct drug-resistant dihydrofolate…”
    Get more information
    Journal Article
  20. 20

    Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors by Katsanis, E, Orchard, P J, Bausero, M A, Gorden, K B, McIvor, R S, Blazar, B R

    “…Murine neuroblastoma, neuro-2a, was transduced with the retroviral vector LIL-2SN in order to examine the influence of localized interleukin (IL)-2 production…”
    Get more information
    Journal Article